Genetic variants in the MRPS30 region and postmenopausal breast cancer risk

Ying Huang, Dennis G. Ballinger, James Y. Dai, Ulrike Peters, David A. Hinds, David R. Cox, Erica Beilharz, Rowan T. Chlebowski, Jacques E. Rossouw, Anne McTiernan, Thomas Rohan, Ross L. Prentice

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

Background: Genome-wide association studies have identified several genomic regions that are associated with breast cancer risk, but these provide an explanation for only a small fraction of familial breast cancer aggregation. Genotype by environment interactions may contribute further to such explanation, and may help to refine the genomic regions of interest.Methods: We examined genotypes for 4,988 SNPs, selected from recent genome-wide studies, and four randomized hormonal and dietary interventions among 2,166 women who developed invasive breast cancer during the intervention phase of the Women's Health Initiative (WHI) clinical trial (1993 to 2005), and one-to-one matched controls. These SNPs derive from 3,224 genomic regions having pairwise squared correlation (r2) between adjacent regions less than 0.2. Breast cancer and SNP associations were identified using a test statistic that combined evidence of overall association with evidence for SNPs by intervention interaction.Results: The combined 'main effect' and interaction test led to a focus on two genomic regions, the fibroblast growth factor receptor two (FGFR2) and the mitochondrial ribosomal protein S30 (MRPS30) regions. The ranking of SNPs by significance level, based on this combined test, was rather different from that based on the main effect alone, and drew attention to the vicinities of rs3750817 in FGFR2 and rs7705343 in MRPS30. Specifically, rs7705343 was included with several FGFR2 SNPs in a group of SNPs having an estimated false discovery rate < 0.05. In further analyses, there were suggestions (nominal P < 0.05) that hormonal and dietary intervention hazard ratios varied with the number of minor alleles of rs7705343.Conclusions: Genotype by environment interaction information may help to define genomic regions relevant to disease risk. Combined main effect and intervention interaction analyses raise novel hypotheses concerning the MRPS30 genomic region and the effects of hormonal and dietary exposures on postmenopausal breast cancer risk.

Original languageEnglish (US)
Article number42
JournalGenome Medicine
Volume3
Issue number6
DOIs
StatePublished - Jun 24 2011

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Genetic variants in the MRPS30 region and postmenopausal breast cancer risk'. Together they form a unique fingerprint.

  • Cite this

    Huang, Y., Ballinger, D. G., Dai, J. Y., Peters, U., Hinds, D. A., Cox, D. R., Beilharz, E., Chlebowski, R. T., Rossouw, J. E., McTiernan, A., Rohan, T., & Prentice, R. L. (2011). Genetic variants in the MRPS30 region and postmenopausal breast cancer risk. Genome Medicine, 3(6), [42]. https://doi.org/10.1186/gm258